In January, specialty pharmacy group contracting organization Armada Health Care introduced ApproveRx, a Web-based system that it says will greatly streamline the prior authorization process and already has been adopted by Amber Pharmacy. Meanwhile, the company also is gearing up for the Armada Summit at the Wynn Las Vegas Hotel in May. Recently, Drug Store News spoke with Armada CEO Larry Irene about these recent developments.
A new study published Thursday by the Center for Healthcare Supply Chain Research identifies factors, based on an analysis of European models, that may affect the American launch of biosimilars and their marketplace potential in the United States.
Following the completion of a joint venture between GlaxoSmithKline and Novartis' consumer health units, Brian McNamara, currently division head, Novartis OTC, will transition to GSK as Head of Americas and Europe for the consumer health businesses.
United Parcel Service said it will expand UPS My Choice and the UPS Access Point network, two of the company’s services that work together to provide online shoppers and global retailers with new personalized solutions to manage residential package deliveries.
Abbott on Wednesday announced that it has received CE Mark (Conformite Europeenne) for its FreeStyle Libre Flash Glucose Monitoring System, a revolutionary new glucose-sensing technology for people with diabetes.
Teva Pharmaceutical on Wednesday announced that a positive judgment has been given by the U.K. High Court in support of Teva's case against AstraZeneca relating to the validity of EP 1,085,877 covering the SMART (Single inhaler Maintenance And Reliever Therapy) indication for AstraZeneca's fixed dose formoterol/budesonide combination product, Symbicort.
Pharmacies in Europe are reportedly stealing market share from beauty retailers like Sephora as they increasingly stock their shelves with natural and organic cosmetic brands, and consumers look to curb spending on higher-priced products, according to a Reuters report.
Although the pace of approvals for new orphan drugs — medicines that treat relatively rare conditions — have increased in the United States and Europe in recent years, patients are facing growing challenges accessing those drugs, a newly completed study released last week by the Tufts Center for the Study of Drug Development at Tufts University has concluded.
As many as 32 organizations on Tuesday signed a letter calling on the Food and Drug Administration to require biologics and biosimilars to have the same International Nonproprietary Name, a practice currently in use in Europe and other markets.
In partnership with Unilever, graduating students in the Fashion Institute of Technology's Cosmetics and Fragrance Marketing and Management Master of Professional Studies program revealed insights into future beauty consumers and the methodologies that beauty companies should adopt to remain competitive.
Personal care company Kimberly-Clark, whose portfolio includes Kotex, has announced executive changes designed to further enhance its focus on executing its global business plan and driving global expansion.
Global consumer confidence held steady at an index of 94 for three consecutive quarters, ending 2013 one point higher than it started and three points higher than the same time period the previous year, according to consumer confidence findings released by Nielsen.
Whether it is rose hip seed oil, Argan oil, jojoba oil, olive oil or Kukui oil, incorporating oil into a skin care regimen is the buzz, and it is likely that the segment will gain even greater attention during 2014.